glp 1 peptid Glucagon-Like Peptide | C149H226N40O45 | CID 16133831 Oral Small-Molecule GLP-1 Receptor Agonists:

[1] [3] Other considerations during the perioperative period may include: Potential for nausea and vomiting Challenges with airway management if emergency intubation is required Effects on post-operative recovery and nutrition Changes in blood glucose control Anaesthetists may modify their approach based on individual risk assessment, potentially including techniques to reduce aspiration risk or additional monitoring

The recommended dosage is one capsule a day, slowly increasing to two capsules before two meals if needed

Both peptides are administered through subcutaneous injections which can be self-administered, however, it is still important to consult a healthcare provider for personalized advice

2014;9:e92222